MARATTO

article · IJTLD OPEN

Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB

20252 citationsOpen accessUniversity André Salifou

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

aSTR was safer than oSTR and both approaches had a similar treatment efficacy.

Research topics

  • Antimicrobial Resistance in Staphylococcus
  • Pneumonia and Respiratory Infections
  • Bacterial Infections and Vaccines

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.5588/ijtldopen.25.0151

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.